The Multiple Myeloma Daily
A selection of articles, blog posts, videos and photos recommended by Robert Z. Orlowski
A selection of articles, blog posts, videos and photos recommended by Robert Z. Orlowski
Multiple myeloma (MM) derives from the clonal proliferation of plasma cells, primarily residing in the bone marrow. However, MM cells can disseminate systemically, leading to…
BackgroundMultiple myeloma (MM) is virtually always preceded by monoclonal gammopathy of undetermined significance (MGUS). Elevated serum markers are used to classify MGUS patients into clinical…
Myeloma Paper of the Day, June 21st, suggested by Robert Orlowski / cancer, Emiko Sakaida, Kazumoto Shibuya, Marie Morooka, MM, Moeko Ogushi, Myeloma, Myeloma
Daratumumab- and elotuzumab-based regimens may be treatment options for refractory POEMS syndrome.
In summary, the cumulative incidence of VTE remains high in patients with TI nMM. DOACs could be the most effective option for preventing VTE.
Myeloma Paper of the Day, June 16th, suggested by Robert Orlowski / Abderrazak El Yamani, Adrienne de Labarthe, Alexis Talbot, Arthur Bobin, Aurore Perrot,
The Consensus Panel 3 (CP3) of the 12th International Workshop on Waldenström macroglobulinemia (IWWM-12) has reviewed and incorporated current data to make recommendations for the…